Frequency of adverse events in patients with poor anticoagulation: a meta-analysis
- Aspirin and the Prevention of Venous Thromboembolism. Becker, Richard C. // New England Journal of Medicine;5/24/2012, Vol. 366 Issue 21, p2028
The article discusses the effectiveness of aspirin in reducing the risk of venous thromboembolism. In 2002, a study found that an antiplatelet therapy led to a 39% reduction in the risk of venous thromboembolism in high-risk patients. It notes that the adverse-event profile of aspirin is...
- SHORT CUTS. Tonks, Alison // BMJ: British Medical Journal (International Edition);9/22/2007, Vol. 335 Issue 7620, p586
The article presents news items related to medicine. A study reported in "Lancet" found that Dabigatran etxilate, an anticoagulant, is as good as enoxaparin for thromboembolic prophylaxis after hip replacement. A study reported in the Journal of the American Medical Association" found that...
- Diet as prophylaxis and treatment for venous thromboembolism? Cundiff, David K.; Agutter, Paul S.; Malone, P. Colm; Pezzullo, John C. // Theoretical Biology & Medical Modelling;2010, Vol. 7, p31
Background: Both prophylaxis and treatment of venous thromboembolism (VTE: deep venous thrombosis (DVT) and pulmonary emboli (PE)) with anticoagulants are associated with significant risks of major and fatal hemorrhage. Anticoagulation treatment of VTE has been the standard of care in the USA...
- How Vitamin K Intake Alters Oral Anticoagulation. Miller, Karl E. // American Family Physician;3/1/2005, Vol. 71 Issue 5, p980
Discusses research being done on the role of dietary vitamin K intake in chronic oral anticoagulation. Reference to a study by V Franco et al published in the May 15, 2004 issue of the "American Journal of Medicine"; Complications in using oral anticoagulation; Importance of stable intake of...
- Dabigatran etexilate. // Reactions Weekly;6/30/2012, Issue 1408, p13
The article describes the case of a 66-year-old woman with renal insufficiency who experienced gastrointestinal bleeding after undergoing dabigatran etexilate therapy for atrial fibrillation.
- Dabigatran etexilate. // Reactions Weekly;9/1/2012, Issue 1417, p19
The article describes the case of an 83-year-old man developed intracranial haemorrhages and subsequently died while undergoing dabigatran etexilate therapy for atrial fibrillation.
- Anticoagulant prescription more common in AF patients, underused in elderly. Byrne, Jen; Costa, Samantha; Swain, Erik; Taliercio, Adam; Volansky, Rob // Cardiology Today;Apr2014, Vol. 17 Issue 4, p55
The article reports that prescription of anticoagulants are more common in atrial fibrillation (AF) patients, but are less used among older people due to concerns of bleeding risk, which was concluded by a study on 3.119 patients with AF enrolled between February 2012 and March 2013.
- Aspirin/clopidogrel/dabigatran etexilate. // Reactions Weekly;1/5/2013, Issue 1433, p10
The article describes several cases of patients who experienced haemorrhagic disorders while undergoing dabigatran-etexilate, aspirin and clopidogrel therapy.
- Dabigatran etexilate. // Reactions Weekly;8/11/2012, Issue 1414, p22
The article describes the case of a 78-year-old man who developed basilar artery occlusion and subsequently died while undergoing dabigatran etexilate therapy.